exv10w40






Exhibit 10.40


CONFIDENTIAL
TREATMENT REQUESTED



Signature Version




License Agreement



This License Agreement (“Agreement”) is made and entered into as of July 31, 2008 (“Effective
Date”), by and among Transmeta Corporation, a Delaware corporation having an office at 2540 Mission
College Blvd., Santa Clara, CA 95054 (“Transmeta”), NVIDIA Corporation, a Delaware corporation
having an office at 2701 San Tomas Expressway, Santa Clara, CA 95050 (“NVIDIA”) and NVIDIA
International, Inc., a Cayman corporation and Barbados international business company having an
office at Chamberlain Place, Broad Street, Bridgetown, Barbados (“NVIDIA Sub”). NVIDIA Sub is a
wholly owned subsidiary of NVIDIA. Each of Transmeta and NVIDIA are referred to herein as a
“Party” and together as the “Parties”.




RECITALS




          A. NVIDIA wishes to obtain from Transmeta, and Transmeta is willing to grant to NVIDIA,
licenses for NVIDIA to use and exploit certain Transmeta-owned intellectual property in connection
with NVIDIA’s products and in accordance with the terms and conditions of this Agreement.




          B. NVIDIA and Transmeta have previously entered into that certain Design Evaluation Agreement,
dated [* * *], pursuant to which NVIDIA has had the opportunity to evaluate certain Transmeta-owned
materials and become familiar with Transmeta’s technologies related to the intellectual property to
be licensed hereunder.




     NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as
follows:



1. DEFINITIONS




     1.1 “Acquiring Person” means a “person” (as such term is used in Sections 13(d) and 14(d) of
the Securities Exchange Act of 1934, as amended) that acquires (a) securities representing a
majority of the voting power of all of a Party’s outstanding voting securities or (b) all or
substantially all of a Party’s assets, without regard to the sale of cash or receivables.



     1.2
“Adaptive Power Control” means [* *
*].



     1.3 “Architecture Technology” means Transmeta’s technologies and source materials described in
Exhibit A attached hereto, as they exist as of the Effective Date of this Agreement.



     1.4 “Change of Control” means, with respect to a Party, the occurrence of any of the following
events: (a) any consolidation or merger of such Party with or into any other entity in which the
holders of such Party’s outstanding shares immediately before such consolidation or merger do not,
immediately after such consolidation or merger, retain stock representing a majority of the voting
power of the surviving entity or stock representing a majority of the voting
power of an entity that wholly owns, directly or indirectly, the surviving entity (any such
entity, a “Merger Partner”); (b) the sale, transfer, or assignment of securities of such Party
representing



 




* * *
Confidential treatment will be requested for portions of this
exhibit. Omissions are designated as [* * *]. A complete
version of this exhibit will be filed separately with the Securities
and Exchange Commission.


 









 




Signature Version





a majority of the voting power of all of such Party’s outstanding voting securities to
an Acquiring Person; or (c) the sale of all or substantially all of such Party’s assets, without
regard to the sale of cash or receivables, to an Acquiring Person.



     1.5 “Exploit” means to make, use, sell, offer for sale, import, distribute, lease, license,
and otherwise dispose of or transfer. Other forms of this term (such as “Exploitation”) shall be
interpreted in accordance with the foregoing definition.



     1.6 “Foundry Product” means a product that (a) is designed, in whole or in substantial part,
by a third party (or on behalf of a third party by anyone other than NVIDIA or an NVIDIA
Subsidiary), (b) does not prominently bear an NVIDIA brand, and (c) is manufactured or
reproduced by or on behalf of NVIDIA or a sublicensed Subsidiary of NVIDIA under circumstances
where all or substantially all of such products are sold, licensed, distributed, or otherwise
transferred by NVIDIA or the sublicensed NVIDIA Subsidiary to that third party (or to customers of,
and as directed by, that third party).



     1.7 “Have Made” means to contract with a third party or parties to perform manufacturing
functions or services (including wafer fabrication, testing, and/or packaging services) for NVIDIA
or an NVIDIA Subsidiary.



     1.8 “Intellectual Property Rights” means Patent rights, mask work rights, copyrights and trade
secret rights. Intellectual Property Rights shall not include, and specifically excludes: (i)
rights in and to trademarks, trade names, logos, service marks, and other designations of source;
and (ii) any rights in design patents and design patent applications.



     1.9 “Licensed Patents” means: (a) the patents and patent applications listed on Exhibit
C attached hereto and corresponding foreign counterpart patents and patent applications, if
any; (b) any application for Patent owned or controlled by Transmeta or any of its Subsidiaries in
the future which has not been filed as of the Effective Date but with respect to which Transmeta or
any of its Subsidiaries has, as of the Effective Date, directed patent counsel to prepare a patent
application (including a provisional patent application); and (c) any Patent that claims a priority
date from any Patent covered by clause (a) or (b) above. Licensed Patent does not include, and
specifically excludes, any patent and patent application with respect to which Transmeta or a
Transmeta Subsidiary would be required to pay a fee or other monetary consideration to a third
party in connection with or respect to the grant of a license or the exercise of rights under such
patent or patent application as contemplated herein.



     1.10 “LongRun2 Technology” means Transmeta’s LongRun2 power management and related
technologies described in Exhibit B attached hereto, as they exist as of the Effective Date
of this Agreement.



     1.11 “NVIDIA Field of Use” means and includes the fields of [* * *].




2









 





Signature Version




     1.12 “NVIDIA Product” means:



          (a) excluding Foundry Products, any product that is designed (in whole or in substantial part)
by or on behalf of NVIDIA or an NVIDIA Subsidiary and is manufactured and/or sold by or on behalf
of NVIDIA or an NVIDIA Subsidiary and that consists entirely or primarily of [* * *]; and




          (b) excluding Foundry Products, in the case where [* * *] (“Driver Software”) was jointly
developed by NVIDIA (or an NVIDIA Subsidiary) and a third party (a “Jointly Developed Product”) and
NVIDIA’s contribution to the Jointly Developed Product (which may or may not include some or all of
the Transmeta Technology) comprises [* * *] Driver Software that provides, in addition to the
functionality provided by the Transmeta Technology, substantial functionality beyond that provided
by the third party, then (i) when the Jointly Developed Product is sold, or the Driver Software is
licensed, by NVIDIA or an NVIDIA Subsidiary, the entire Jointly Developed Product will be
considered an NVIDIA Product, and (ii) when the Jointly Developed Product is sold, or the Driver
Software is licensed, by the third party (or any of its subsidiaries) that jointly developed the
product, only that portion of the Jointly Developed Product that was developed by NVIDIA or an
NVIDIA Subsidiary (the “NVIDIA Subsystem”) will be considered an NVIDIA Product (provided, however,
that none of such Jointly Developed Product will be considered an NVIDIA Product if the NVIDIA
Subsystem has no substantial functionality other than Adaptive Power Control).




     1.13 “Patent(s)” means all classes and types of patents (including originals, divisions,
continuations, continuations-in-part, extensions or reissues), and applications for these classes
or types of patents, throughout the world, with the exception of design patents and design patent
applications.



     1.14 “Subsidiary” means any corporation, partnership, limited liability company, or other
entity recognized in any jurisdiction in the world, now or hereafter, in which a Party owns or
controls (either directly or indirectly), now or hereafter, greater than fifty percent (50%) of the
voting power of the outstanding shares or stock or securities entitled to vote for the election of
directors or similar managing authority, or (if such entity does not have voting shares or stock or
other voting securities) greater than fifty percent (50%) of the voting power of the ownership
interest that represents the right to make decisions for such entity. An entity shall be deemed to
be a Subsidiary under this Agreement only so long as the Party to which such Subsidiary relates:
(a) continues to own or control shares, stock, securities or other ownership interest in that
entity at the level required above; and (b) has not contractually or otherwise surrendered or in
any other material way constrained its authority to elect the managing authority or make decisions
for the entity.



     1.15 “Transmeta Technology” means, collectively, the Architecture Technology and the LongRun2
Technology.



     1.16 “Transmeta Technology Deliverables” means the electronic documentation and other computer
files that describe, document, or embody each element of the Transmeta Technology identified in
Exhibit A or Exhibit B.



3









 





Signature Version




2. LICENSE




     2.1 License Grant. Subject to the terms and conditions of this Agreement, Transmeta,
on behalf of itself and its Subsidiaries, grants to NVIDIA a worldwide, nonexclusive, perpetual,
irrevocable and non-terminable (except as expressly provided in Section 8.2), nontransferable and
non-assignable (except as set forth in Section 14.1), non-sublicensable (except as set forth in
Section 2.2) and fully-paid-up license under all of the Licensed Patents and all Intellectual
Property Rights in the Transmeta Technology and Transmeta Technology Deliverables owned or
controlled by Transmeta or any of its Subsidiaries, to:



          (a) Exploit and Have Made NVIDIA Products; and




          (b) use, reproduce, modify, and create derivative works of the Transmeta Technology
Deliverables in connection with the design, development, manufacturing, testing, distribution,
and/or sale of NVIDIA Products.




If any action on the part of any Transmeta Subsidiary is necessary to make the license grant above
fully effective, Transmeta shall ensure that such Subsidiary takes such action.



     2.2 Sublicensing. NVIDIA has the right to sublicense any (or all) of the license
rights granted in Section 2.1 to any one or more NVIDIA Subsidiaries. NVIDIA, however, will be
responsible for the acts and omissions of each and every such NVIDIA Subsidiary with respect to the
terms and conditions of this Agreement as if they were acts and omissions of NVIDIA itself. NVIDIA
also has the right: (a) to sublicense to suppliers (including foundries and other contract
manufacturers) any or all of the license rights granted in Section 2.1, solely as necessary for
NVIDIA or any of its Subsidiaries to exercise the Have Made rights granted above; and (b) to
sublicense to NVIDIA’s and its Subsidiaries’ direct and indirect customers and NVIDIA’s and its
Subsidiaries’ distributors the rights to use and, in the case of distributors, distribute, sell,
offer for sale, lease, and license the NVIDIA Products furnished by NVIDIA or its Subsidiary.
NVIDIA may distribute and disclose the Transmeta Technology Deliverables to any Subsidiary or other
authorized sublicensee, solely for such entity’s use in the exercise of the rights sublicensed to
it by NVIDIA, subject to the terms of Section 9 below.



     2.3 Limitations. NVIDIA expressly acknowledges that the license rights granted in
Sections 2.1 and 2.2 above are subject to the following limitations, restrictions, and conditions,
and agrees to abide by all such limitations, restrictions, and conditions, as follows:



          (a) The licenses granted under this Agreement do not authorize NVIDIA, or any sublicensed
NVIDIA Subsidiary, to manufacture (or have manufactured) products on behalf of any third party as a
foundry, contract manufacturer, or in any similar capacity. By way of illustration and without
limiting the foregoing, NVIDIA is not authorized to practice or use the Licensed Patents, Transmeta
Technology, or Transmeta Technology Deliverables to make or Have Made any products based on any
design that (in whole or in substantial part) has been provided to NVIDIA by a third party, where
such products are to be supplied substantially exclusively to such third party or substantially
exclusively to customers of, and as directed by, such third party.




4









 








Signature Version




          (b) In the event of any assignment or transfer to a third party of this Agreement by NVIDIA,
whether by operation of law, in connection with a Change of Control, or otherwise (for example and
without limitation, in connection with or as a result of a merger of NVIDIA into a third party or
the acquisition of NVIDIA’s assets by a third party), the licenses granted under this Agreement
shall not extend to cover any pre-existing products of the Merger Partner or Acquiring Person, any
subsequent versions thereof that are substantially based upon the design of such pre-existing
products of the Merger Partner or Acquiring Person, or any later-released products of the Merger
Partner or Acquiring Person that are not substantially based on a product that was an NVIDIA
Product immediately prior to the assignment or other transfer of this Agreement. However, for
avoidance of doubt, the licenses granted under this Agreement will continue to apply to the NVIDIA
Products as they existed immediately prior to such assignment or transfer and to any subsequent
versions thereof that are substantially based upon the design of such pre-existing NVIDIA Products.




          (c) NVIDIA’s and its Subsidiaries’ rights in and to the Licensed Patents and in and to the
Transmeta Technology, Transmeta Technology Deliverables, and Transmeta’s Intellectual Property
rights therein, are limited to those licenses and rights expressly granted in this Agreement.
Transmeta reserves for itself all rights in and to the Licensed Patents, Transmeta Technology,
Transmeta Technology Deliverables and Intellectual Property Rights therein not expressly granted to
NVIDIA hereunder. For the avoidance of doubt, NVIDIA is not deemed to be an acquiror or assignee
of, or successor to, Transmeta or any of its Subsidiaries by reason of this Agreement.




          (d) In the event of any Change of Control of Transmeta or any of its Subsidiaries, or any
assignment or transfer of this Agreement by Transmeta, the licenses granted pursuant to this
Agreement shall not be construed as granting any rights under, or as otherwise applying to, any
Intellectual Property Rights of the Merger Partner, Acquiring Person, or other acquirer, assignee,
transferee, or successor of Transmeta or the applicable Subsidiary, except to the extent such
Intellectual Property Rights would otherwise be subject to the licenses granted above in the
absence of such Change of Control, assignment, transfer, or succession.




3. DELIVERY



Following the execution of this Agreement by both Parties, Transmeta will deliver the Transmeta
Technology Deliverables to NVIDIA by means of electronic delivery (e.g., by FTP download), by a
“Load and Leave” process, or by other means reasonably acceptable to the Parties, it being
understood that Transmeta shall have no obligation, and has no intent, to deliver any tangible
articles to NVIDIA under this Agreement. NVIDIA acknowledges that it has been given a full and
reasonable opportunity to review, and has reviewed, the Transmeta Technology Deliverables prior to
execution of this Agreement, and that Transmeta shall have no obligation under the preceding
sentence to deliver any items beyond those previously made available for NVIDIA’s review. Except
as set forth in this Section 3, Transmeta will have no obligation to furnish NVIDIA or any of its
Subsidiaries with any technology, information, materials, services, updates, support, or assistance
of any kind. NVIDIA acknowledges and agrees that in no event shall Transmeta have any obligation
to create or develop, or deliver to NVIDIA, any new technology, information, materials, or data.
Upon completion of the delivery set forth in the first sentence of this Section 3, Transmeta shall
have fully and completely satisfied its delivery obligation under this Agreement to deliver the
Transmeta Technology Deliverables to NVIDIA.




5









 








Signature Version




4. COVENANT NOT TO SUE




     4.1 Covenant by Transmeta. For a period of [* * *] following the Effective
Date, and contingent upon receipt by Transmeta of the entire License Fee set forth in Section 6.1,
Transmeta covenants that it will not assert, and it will ensure that none of its Subsidiaries
asserts, any claim of infringement of any Patent against (a) NVIDIA or any of its Subsidiaries
based upon the manufacture, use, sale, offer for sale, or importation of products or services that
are within the NVIDIA Field of Use or (b) with respect to their use of any products or services
within the NVIDIA Field of Use that are provided by NVIDIA or any of its Subsidiaries, any of its
or their direct or indirect customers (including end users), suppliers (including licensors), or
distributors.



     4.2 Covenant by NVIDIA. For a period of [* * *] following the Effective Date,
NVIDIA covenants that it will not assert, and it will ensure that none of its Subsidiaries asserts,
any claim of infringement (including contributory infringement and inducing infringement) of any
Patent against Transmeta or any of its Subsidiaries based upon or arising from the licensing by
Transmeta or any its Subsidiaries to any third party of the Transmeta Technology and/or Licensed
Patents, including the provision by Transmeta or any of its Subsidiaries of the Transmeta
Technology Deliverables to any third party. This covenant is not intended to exhaust any of
NVIDIA’s or its Subsidiaries’ patents or confer any rights or benefits on any third party,
including any licensee of Transmeta or its Subsidiaries. This covenant will apply to Transmeta and
its Subsidiaries only when Transmeta or a Transmeta Subsidiary grants a license to the Transmeta
Technology or Licensed Patents to a third party (a “Licensee”) in a binding written agreement that
includes an express acknowledgement by the Licensee that no rights in any NVIDIA patents are
granted or conferred upon the Licensee as a result of the exhaustion doctrine or the doctrine of
implied licenses or otherwise.



     4.3 Beneficiaries; Termination. The covenants set forth in Sections 4.1 and 4.2 do
not and will not bind or benefit any third party, except as expressly set forth above. The
covenants set forth above will immediately and automatically terminate upon the earlier of: (a) the
[* * *] of the Effective Date; and (b) a Change of Control of either NVIDIA or Transmeta.
Further, except in connection with a Change of Control, any transfer or assignment of this
Agreement or the covenant obligations or covenant rights hereunder by a Party to any third party
will automatically terminate the other Party’s and its Subsidiaries’ covenant under this Section 4.



5. RELEASE




     5.1 Release of Actions Prior to Effective Date. Following the execution of this
Agreement by both Parties, and contingent upon receipt by Transmeta of the entire License Fee set
forth in Section 6.1, each Party (as “Releasor”), on behalf of itself and its Subsidiaries as of
the Effective Date, releases the other Party, all of such other Party’s Subsidiaries as of the
Effective Date, and all of its and their respective current and former officers, employees, agents,
directors, shareholders, and owners (collectively, the “Representatives”) from any and all claims
of infringement of any Patent owned or controlled by the Releasor or its Subsidiaries based upon
activities occurring on or before the Effective Date. In addition, each Releasor, on behalf of
itself and its Subsidiaries as of the Effective Date, releases the other Party’s and its
Subsidiaries’ suppliers (including licensors) and direct and indirect customers (including end
users) from all claims of infringement of any Patent owned or controlled by the Releasor or its
Subsidiaries



6









 





Signature Version




based upon the manufacture, use, sale (or license), offer for sale (or license), or
importation of products or services provided by the other Party or any of its Subsidiaries on or
before the Effective Date. If any action on the part of any Subsidiary of a Party is necessary to
make the releases above fully effective, such Party shall ensure that such Subsidiary takes such
action.



     5.2 Release of Unknown Claims. The release contained in this Agreement extends to
claims to which the Parties and their respective Subsidiaries do not know or suspect to exist in
their favor, which if known by them, would have materially affected their decision to enter into
the release contained in this Agreement. Each of the Parties, on behalf of itself and its
Subsidiaries as of the Effective Date, acknowledges that it is familiar with Section 1542 of the
Civil Code of the State of California, which is quoted as follows:




A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW, OR SUSPECT TO
EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE WHICH IF KNOWN BY HIM MUST HAVE
MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.



     The Parties expressly waive their right under Section 1542 as to any unknown claims within the
scope of the release under this Agreement. Notwithstanding the foregoing, the Parties acknowledge
and agree that the release given under this Section 5 is limited to claims of patent infringement
and is not a “general release” of any other related claims, known or unknown, that may be based on
a common set of transactions or occurrences or depend on a common nucleus of operative facts.



     5.3 Claims not Released. Notwithstanding anything set forth in this Section 5 or
elsewhere in this Agreement, nothing in this Agreement is or will be effective to release a Party,
its Subsidiaries or that Party’s or its Subsidiaries’ Representatives, suppliers (including
licensors) and direct and indirect customers (including end users) from any claims an acquiror,
transferee, assignee, or successor of the Releasor or of the Releasor’s Subsidiaries may have prior
to the effective date of such acquisition, transfer, assignment, or succession.



6. PAYMENTS




     6.1 License Fee. Within [* * *] business days after Transmeta’s delivery of the
Transmeta Technology Deliverables pursuant to the first sentence of Section 3, and subject to
Section 6.2 below, NVIDIA will pay (or will cause NVIDIA Sub to pay) to Transmeta a one-time,
non-refundable license fee of twenty-five million United States dollars (U.S. $25,000,000)
(“License Fee”). Transmeta will credit twenty-five thousand United States dollars (U.S. $25,000)
of the License Fee to the Fees owed by NVIDIA to Transmeta pursuant to that certain Design
Evaluation Agreement between the Parties dated [* * *].



     6.2 Payment Terms. The entire amount of the License Fee specified in this Agreement
will be paid in U.S. dollars. NVIDIA shall pay (or will cause NVIDA Sub to pay) the entire License
Fee to Transmeta, without deduction or withholding of taxes or other fees or costs, by wire
transfer for the account of Transmeta to such account as Transmeta may indicate by written notice
to NVIDIA. Transmeta will provide written notice of its wire transfer instructions to NVIDIA no
later than [* * *] business days after its initial delivery of the Transmeta Technology
Deliverables to NVIDIA pursuant to the first sentence of Section 3. If



7









 




 Signature Version



Transmeta fails to provide written notice of its wire transfer instructions to NVIDIA by then,
then for each additional day before Transmeta provides such written notice to NVIDIA, NVIDIA will
have an additional day to pay the License Fee to Transmeta.



7. PUBLICITY



Promptly after execution of this Agreement by both Parties, NVIDIA and Transmeta will cooperate
with one another to prepare and issue a mutually agreed-upon press release regarding the
relationship established by this Agreement. Neither Party shall issue any other press release or
other public statement regarding this Agreement or either Party’s rights or obligations hereunder
without the other Party’s prior written approval of such press release or other public statement,
which approval shall not be unreasonably withheld or delayed.




8. TERM AND TERMINATION




     8.1 Term. This Agreement will begin on the Effective Date and will remain in force
perpetually unless and until terminated in accordance with Section 8.2.



     8.2 Termination of Agreement. Transmeta will have the right to terminate this
Agreement, including the licenses granted in Section 2, by written notice to NVIDIA due to NVIDIA’s
failure to pay the License Fee as set forth in Section 6, if such failure is not corrected within
ten (10) business days after Transmeta provides written notice thereof to NVIDIA. Transmeta will
not have the right to terminate this Agreement, or any license rights granted to NVIDIA in this
Agreement, for any other reason including any other breach of this Agreement by NVIDIA. Both
Parties acknowledge that Transmeta will have the right to seek other remedies, including monetary
damages and injunctive relief, for any breach of this Agreement by NVIDIA, and without limiting or
waiving any such other remedies, Transmeta irrevocably and unconditionally waives any right it may
have, under any principle of equity or any other legal theory, to terminate any of the license
rights granted to NVIDIA in this Agreement due to any breach of this Agreement (other than the
obligation to pay the License Fee) by NVIDIA or any other act, conduct, or omission on the part of
NVIDIA (other than a failure to pay the License Fee). NVIDIA may not terminate this Agreement for
any reason.



     8.3 Effect of Termination of Agreement. Upon termination of this Agreement by
Transmeta pursuant to Section 8.2: (i) all license rights of NVIDIA under Section 2.1, and all
sublicenses granted under Section 2.2, will immediately and automatically terminate; and
(ii) NVIDIA and its sublicensed Subsidiaries shall promptly return to Transmeta or destroy all
copies, in whatever form, of the Transmeta Technology Deliverables in its or their possession or
control (and, to the extent commercially reasonable, any copies provided by NVIDIA or an NVIDIA
Subsidiary that are in the possession or control of any third party).



     8.4 Survival. The rights and obligations of the Parties under Sections 8.3, 8.4, 9,
10, 11, 12, 13 and 14 of this Agreement will survive termination of this Agreement for any reason.



9. CONFIDENTIALITY




     9.1 Confidentiality Obligations. NVIDIA, on behalf of itself and its Subsidiaries,
acknowledges and agrees that the Transmeta Technology and Transmeta Technology



8









 




Signature Version



Deliverables may contain valuable proprietary, confidential and trade secret information of
Transmeta. Accordingly, NVIDIA will restrict the disclosure of the Transmeta Technology and
Transmeta Technology Deliverables to its Subsidiaries and to suppliers (including foundries and
other contract manufacturers), customers, and distributors as allowed under Sections 2.1 and 2.2,
and will not use the Transmeta Technology or Transmeta Technology Deliverables in a manner that is
outside the scope of the license rights granted to NVIDIA in this Agreement and, with respect to
copyrighted materials included in the Transmeta Technology Deliverables, would not be considered
“fair use” of those materials within the meaning of U.S. copyright law. NVIDIA and its
Subsidiaries shall use at least the efforts and procedures that NVIDIA ordinarily uses with respect
to its own confidential information and trade secrets, but in no event will NVIDIA use less than
reasonable efforts, to protect and to maintain the confidentiality of all of the Transmeta
Technology and Transmeta Technology Deliverables while the Transmeta Technology and Transmeta
Technology Deliverables are in the possession or control of NVIDIA or its Subsidiaries. When
disclosing the Transmeta Technology or Transmeta Technology Deliverables to third parties as
allowed under Sections 2.1 and 2.2, NVIDIA and its Subsidiaries will use the same efforts and
procedures to protect the confidentiality of the Transmeta Technology or Transmeta Technology
Deliverables being disclosed as NVIDIA and its Subsidiaries use to protect their own confidential
information of similar nature and value.



     9.2 Equitable Relief. NVIDIA, on behalf of itself and its Subsidiaries, acknowledges
and agrees that, in the event of a breach by NVIDIA or its Subsidiaries of the restrictions,
limitations, or conditions set forth in this Agreement with respect to the disclosure and/or use of
the Transmeta Technology and the Transmeta Technology Deliverables, in addition to any and all
other remedies available at law, in equity or otherwise to Transmeta and its Subsidiaries,
Transmeta and its Subsidiaries shall have the right to seek specific performance, a temporary
restraining order, preliminary and permanent injunctions and any other appropriate equitable relief
restraining and remedying any breach or threatened breach of the requirements of confidentiality or
any other restrictions, limitations, or conditions on use or disclosure set forth in this
Agreement.



     9.3 Confidentiality of this Agreement. Neither Party shall disclose this Agreement or
any portion thereof without the prior written consent of the other Party.



     9.4 Disclosure Exceptions. The foregoing obligations of Section 9.3 shall not
restrict either Party from disclosing the terms of this Agreement: (i) pursuant to the order or
requirement of a court, administrative agency, or other governmental body, provided that the Party
required to make such a disclosure gives reasonable notice to the other Party, to the extent
reasonably practicable, so that the other Party may contest such an order or requirement or seek
confidential treatment; (ii) on a confidential basis to its legal or professional advisors; (iii)
as required under applicable securities laws, rules and regulations; (iv) subject to execution of
reasonable and customary written confidentiality agreements consistent with the restrictions set
forth herein, to present or future providers of capital and/or potential acquirers of such Party or
its assets associated with the subject matter of this Agreement; and (v) as required to enforce its
rights under the Agreement.



     9.5 Exclusions. The obligations set forth in Section 9.1 will not apply to any
information that: (i) is or becomes generally known to the public through no fault or breach of
this Agreement by the receiving Party; (ii) was rightfully known to the receiving Party at the



9









 




Signature Version




time of disclosure without an obligation of confidentiality owned to the disclosing Party;
(iii) was independently developed by the receiving Party without use of the disclosing Party’s
Confidential Information; or (iv) the receiving Party rightfully obtains from a third Party without
restriction on use or disclosure.



10. OWNERSHIP




     10.1 Intellectual Property Ownership. It is acknowledged and agreed by the Parties
that nothing in this Agreement shall affect either Party’s ownership of any Intellectual Property
Rights, whether existing as of the Effective Date or arising thereafter.



     10.2 Proprietary Notices. NVIDIA and its Subsidiaries will not delete or in any
manner alter the patent, copyright, trademark, and other proprietary rights notices of Transmeta
(and its suppliers, if any) appearing on the documents and computer readable media (including the
Transmeta Technology and/or Transmeta Technology Deliverables), as provided or otherwise made
available by Transmeta hereunder.



11. NO WARRANTIES



THE LICENSED PATENTS, TRANSMETA TECHNOLOGY, AND TRANSMETA TECHNOLOGY DELIVERABLES ARE LICENSED AND
MADE AVAILABLE BY TRANSMETA UNDER THIS AGREEMENT “AS IS” AND WITH ALL FAULTS. TO THE FULLEST
EXTENT PERMITTED BY APPLICABLE LAW, TRANSMETA EXPRESSLY DISCLAIMS ANY AND ALL WARRANTIES AND
CONDITIONS WITH RESPECT TO THE LICENSED PATENTS, TRANSMETA TECHNOLOGY, AND TRANSMETA TECHNOLOGY
DELIVERABLES, EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING: (a) ANY WARRANTY OR
REPRESENTATION AS TO THE VALIDITY, SCOPE, OR ENFORCEABILITY OF THE LICENSED PATENTS OR THAT
NVIDIA’S EXERCISE OF THE RIGHTS GRANTED HEREUNDER WILL NOT INFRINGE THE RIGHTS OF ANY THIRD
PARTIES; AND (b) ANY IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, COMPLETENESS,
SUFFICIENCY, FITNESS FOR A PARTICULAR PURPOSE, QUALITY, OR NON-INFRINGEMENT; EVEN IF TRANSMETA HAS
BEEN MADE AWARE OF ANY PARTICULAR NVIDIA REQUIREMENTS. THE TRANSMETA TECHNOLOGY AND TRANSMETA
TECHNOLOGY DELIVERABLES INCLUDE MATERIALS THAT ARE SUBJECT TO OPEN-SOURCE LICENSING TERMS AND
CONDITIONS.




12. INDEMNITY



Subject to Section 13, NVIDIA agrees to and shall defend, at its own expense, and indemnify
Transmeta and its Subsidiaries for all monetary damages finally awarded or agreed to in settlement
as a result of:





	 	(a)	 	any claims of patent infringement (including contributory infringement and
inducing infringement) asserted in any legal action or proceeding by a Potential Patent
Claimant (as defined in Exhibit D) against Transmeta or its Subsidiaries to the extent
(and solely to the extent) that such claims are based on NVIDIA’s, its Subsidiaries’,
or any of its or their sublicensees’, joint development partners’,




10









 





Signature Version



	 	 	 	direct and indirect customers’, or agents’ Exploitation or other use of the
Transmeta Technology or Transmeta Technology Deliverables licensed or provided to
NVIDIA pursuant to this Agreement; or
	 
	 	(b)	 	any third-party claims for breach of confidentiality, misappropriation of trade
secrets, or copyright infringement arising solely from (i) Transmeta’s delivery or
disclosure to NVIDIA of Third Party Materials included in the Transmeta Technology
Deliverables or (ii) NVIDIA’s or its Subsidiaries’ Exploitation of such Third Party
Materials. As used above, “Third Party Materials” means data, works of authorship,
proprietary or confidential information, software code, or other information or
materials that Transmeta or a Transmeta Subsidiary has lawfully obtained from a third
party (without breaching any contract, infringing any copyrights, misappropriating any
trade secrets, or otherwise engaging in any activity or conduct that is illegal or
violates a third party’s rights) prior to its delivery or disclosure thereof to NVIDIA.





NVIDIA’s obligations under this Section 12 are subject to the following conditions:





	 	(i)	 	Transmeta must give NVIDIA prompt written notice of the claims for which
Transmeta seeks indemnification;
	 
	 	(ii)	 	Transmeta must tender complete control of the defense and settlement of such
claims to NVIDIA (except that NVIDIA may not agree, without Transmeta’s prior written
consent, to any settlement that would impose any material restriction, liability, or
obligation on Transmeta or its Subsidiaries, including any material restriction on
Transmeta’s or its Subsidiaries’ right to Exploit the Transmeta Technology or Licensed
Patents, or any obligation that would require Transmeta or any of its Subsidiaries to
license, transfer, or otherwise dispose of any material portion of the Transmeta
Technology or Licensed Patents, it being understood that Transmeta will not
unreasonably withhold such consent); and
	 
	 	(iii)	 	Transmeta must reasonably cooperate with NVIDIA in the defense of such claims.





13. LIMITATION OF LIABILITY




     13.1 Exclusion of Damages. EXCEPT WITH RESPECT TO ANY BREACH OF NVIDIA’S OR ITS
SUBSIDIARIES’ OBLIGATIONS UNDER SECTION 9.1, OR ANY VIOLATION OF THE LIMITATIONS OR RESTRICTIONS ON
THE SCOPE OF THE LICENSES GRANTED TO NVIDIA HEREUNDER, NEITHER PARTY (INCLUDING ITS SUBSIDIARIES)
WILL BE LIABLE TO THE OTHER PARTY OR ITS SUBSIDIARIES FOR ANY INCIDENTAL, SPECIAL, PUNITIVE,
EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING DAMAGES BASED ON LOSS OF USE, DATA, BUSINESS,
PROFITS, OR GOODWILL OR BASED ON COST OF COVER) IN CONNECTION WITH, ARISING OUT OF, OR RELATING TO
THIS AGREEMENT OR ANY USE BY NVIDIA (OR ANY OF ITS SUBSIDIARIES, AGENTS OR DIRECT OR INDIRECT
CUSTOMERS) OF THE LICENSED PATENTS, TRANSMETA TECHNOLOGY, OR TRANSMETA TECHNOLOGY DELIVERABLES,
WHETHER SUCH LIABILITY ARISES FROM ANY



11









 





Signature Version




CLAIM BASED UPON CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE), PRODUCT LIABILITY OR
OTHERWISE, AND WHETHER OR NOT IT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THIS SECTION
13.1 SHALL NOT, HOWEVER, BE CONSTRUED AS LIMITING (a) EITHER PARTY’S LIABILITY FOR INFRINGEMENT OR
MISAPPROPRIATION OF THE OTHER PARTY’S INTELLECTUAL PROPERTY RIGHTS, or (b) THE AMOUNT OF MONETARY
DAMAGES FINALLY AWARDED BY A COURT, OR AGREED TO IN A SETTLEMENT, FOR WHICH NVIDIA IS OBLIGATED TO
INDEMNIFY TRANSMETA PURSUANT TO SECTION 12.



     13.2 Total Liability



          (a) IN NO EVENT WILL TRANSMETA’S TOTAL CUMULATIVE LIABILITY TO NVIDIA IN CONNECTION WITH,
ARISING OUT OF, OR RELATING TO THIS AGREEMENT, FROM ALL CAUSES OF ACTION AND THEORIES OF LIABILITY,
EXCEED [* * *] U.S. DOLLARS ($[* * *]).




          (b) EXCEPT FOR ANY FAILURE BY NVIDIA TO PAY THE LICENSE FEE AS SET FORTH IN SECTION 6 AND AS
EXPRESSLY PROVIDED IN SECTION 13.2(c), IN NO EVENT WILL NVIDIA’S TOTAL CUMULATIVE LIABILITY TO
TRANSMETA IN CONNECTION WITH, ARISING OUT OF, OR RELATING TO THIS AGREEMENT, FROM ALL CAUSES OF
ACTION AND THEORIES OF LIABILITY (INCLUDING NVIDIA’S OBLIGATIONS UNDER SECTION 12), EXCEED [* * *]
U.S. DOLLARS ($[* * *]).




          (c) IN NO EVENT WILL NVIDIA’S AND ITS SUBSIDIARIES’ TOTAL CUMULATIVE LIABILITY TO TRANSMETA IN
CONNECTION WITH, ARISING OUT OF, OR RELATING TO ANY BREACH OF NVIDIA’S OBLIGATIONS UNDER SECTION
9.1 OR ANY LIABILITY FOR NVIDIA’S OR ITS SUBSIDIARIES’ INFRINGEMENT OR MISAPPROPRIATION OF
TRANSMETA’S OR ITS SUBSIDIARIES’ INTELLECTUAL PROPERTY RIGHTS EXCEED [* * *] U.S. DOLLARS ($[* *
*]).




     13.3 Acknowledgment. Each Party acknowledges that the other Party has entered into
this Agreement in reliance on the above limitations and exclusions of liability, and on NVIDIA’s
promise to indemnify, defend, and hold harmless Transmeta as set forth in Section 12 above, and
that the same constitute a material basis of the bargain between the Parties, without which neither
Party would enter into this Agreement. The Parties have agreed that the limitations and exclusions
specified above will survive any expiration or termination of this Agreement and will apply even if
any limited remedy specified in this Agreement is found to have failed of its essential purpose.



14. GENERAL PROVISIONS




     14.1 Assignment. Neither Party may assign or transfer this Agreement and/or any
rights and/or obligations hereunder, in whole or in part, whether by operation of law or otherwise,
without the other Party’s express prior written consent, which consent will not be unreasonably
withheld or delayed. Notwithstanding the immediately preceding sentence, either Party may assign
or transfer this Agreement in connection with a Change of Control of that Party to a Merger Partner
or the Acquiring Person in that Change of Control. Any attempt to assign or




12











 





Signature Version



transfer this Agreement other than as specifically permitted by this Section 14.1 shall be
null and void and without effect. Any assignment or transfer of this Agreement shall be subject to
the provisions of Section 2.3(b), Section 2.3(d) and Section 4. Subject to the foregoing or as
provided otherwise in this Agreement, the rights and obligations of the Parties will be binding
upon and inure to the benefit of the Parties’ permitted successors and lawful transferees and
assigns.




     14.2 Independent Contractors. In performing their respective duties under this
Agreement, each of the Parties will be operating as an independent contractor. Nothing contained
herein will in any way constitute any association, partnership, or joint venture between the
Parties hereto. Neither Party will have the power to bind the other Party or incur obligations on
the other Party’s behalf without the other Party’s prior written consent.



     14.3 Notice. All notices required or permitted under this Agreement will be in
writing and delivered by confirmed facsimile transmission, by courier or overnight delivery
services, or by certified mail, and in each instance will be deemed given upon receipt. All
communications will be sent to the addresses set forth below or to such other address as may be
specified by either Party to the other in accordance with this Section. Either Party may change
its address for notices under this Agreement by giving written notice to the other Party by the
means specified in this Section.



	 	 	 	 
	 

	If to Transmeta:
	 	If to NVIDIA and/or NVIDIA Sub:
	 
	 	 	 
	 

	President
	 	Chief Financial Officer
	 

	Transmeta Corporation
	 	NVIDIA Corporation
	 

	2540 Mission College Blvd.
	 	2701 San Tomas Expressway
	 

	Santa Clara, CA 95054
	 	Santa Clara, CA 95050
	 
	 

	With copies to:
	 	With copy to:
	 

	General Counsel
	 	General Counsel
	 

	Transmeta Corporation
	 	NVIDIA Corporation
	 

	2540 Mission College Blvd.
	 	2701 San Tomas Expressway
	 

	Santa Clara, CA 95054
	 	Santa Clara, CA 95050
	 
	 	 	 
	 

	Mark A. Leahy, Esq.	 	 
	 

	Fenwick & West LLP	 	 
	 

	801 California Street	 	 
	 

	Mountain View, CA 94041	 	 






     14.4 Compliance with Export Control Laws. NVIDIA will comply fully with all relevant
export laws and regulations of the United States and all other countries having competent
jurisdiction (“Export Laws”) to ensure that neither the Transmeta Technology, Transmeta Technology
Deliverables nor any direct product thereof or technical data related thereto is: (i) exported or
re-exported directly or indirectly in violation of Export Laws; or (ii) used for any purposes
prohibited by the Export Laws, including nuclear, chemical, or biological weapons proliferation.



13









 





Signature Version




     14.5 Waiver. No failure by either Party to exercise or enforce any of its rights
under this Agreement will act as a waiver of such rights, and no waiver of a breach in a particular
situation will be held to be a waiver of any other or subsequent breach.



     14.6 Severability. If any provision of this Agreement is found invalid or
unenforceable, that provision will be enforced to the maximum extent possible, and the other
provisions of this Agreement will remain in force.



     14.7 Non-Exclusive Remedy. Except as otherwise set forth in this Agreement, the
exercise by either Party of any of its remedies under this Agreement will be without prejudice to
its other remedies under this Agreement or otherwise.



     14.8 Governing Law and Venue. This Agreement will be governed by and construed in
accordance with the laws of the State of California without reference to its conflict of laws
principles. Any legal action or proceeding arising under this Agreement will be brought
exclusively in the federal or state courts located in the Northern District of California and the
Parties hereby irrevocably: (a) consent to the personal jurisdiction of such courts and venue
therein; and (b) waive any objections based on any such court’s inconvenience as a forum.



     14.9 Construction. No rule of strict construction shall be applied in the
interpretation of this Agreement. Section headings are for convenience only and are not to be
taken into consideration in the interpretation of this Agreement. Unless otherwise expressly
stated in this Agreement: (a) the words “including” and “includes”, and any variations thereof,
will be read as if followed by the words “without limitation” and shall not be taken as expressions
of limitation; and (b) whenever a Party’s consent or approval is required, such Party may grant or
withhold such consent or approval in its absolute discretion.



[REMAINDER OF PAGE INTENTIONALY LEFT BLANK.]




14









 





Signature Version




     14.10 Entire Agreement. This Agreement, including its exhibits, constitutes the
complete and exclusive understanding and agreement between the Parties relating to the subject
matter hereof and supersedes all contemporaneous and prior understandings, agreements, and
communications (both written and oral) relating to its subject matter. No modifications,
alterations, or amendments will be effective unless in writing signed by duly authorized
representatives of both Parties.



     14.11 Counterparts. This Agreement may be executed in multiple counterparts, each of
which will be deemed an original but all of which together will constitute one and the same
instrument.



     IN WITNESS WHEREOF, the Parties and NVIDIA Sub have caused this Agreement to be executed by
their duly authorized representatives, to be effective as of the Effective Date.



	 	 	 	 	 	 	 	 	 	 	 
	TRANSMETA CORPORATION:	 	 	 	NVIDIA CORPORATION:	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ LESTER M. CRUDELE
	 	 	 	By:
	 	/s/ DAVID M. SHANNON	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	Name:

	 	Lester M. Crudele
	 	 	 	Name:
	 	David M. Shannon	 	 
	Title:

	 	President & Chief Executive Officer
	 	 	 	Title:
	 	General Counsel	 	 
	Date:

	 	July 31, 2008
	 	 	 	Date:
	 	July 31, 2008	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	NVIDIA International, Inc.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	By:
	 	/s/ NIGEL B. ALLEN	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name:
	 	Nigel B. Allen	 	 
	 

	 	 	 	 	 	Title:
	 	Director	 	 
	 

	 	 	 	 	 	Date:
	 	July 31, 2008	 	 






15









 






Signature Version




EXHIBIT A




Architecture Technology




[* * *]




16









 





Signature Version




EXHIBIT B




LongRun2 Technology



[* * *]


17









 








Signature Version




EXHIBIT C




Licensed Patents



Transmeta represents and warrants that Exhibit C contains a complete and accurate list of all U.S.
patent applications (including continuations, continuations in part, and divisionals) and issued
U.S. patents (including reissues and reexaminations) that are in Transmeta’s possession, custody,
or control, or that Transmeta has the right or ability to license, as of the Effective Date.
Transmeta further represents and warrants that each non-U.S. patent or patent application owned or
controlled by Transmeta or any of its Subsidiaries as of the Effective Date is a foreign
counterpart of at least one of the U.S. patents or patent applications listed below and, therefore,
is a Licensed Patent.




[* * *]




19









 





Signature Version




EXHIBIT D




Potential Patent Claimants




[* * *]




20